Adenosine 5'-tetraphosphate (Ap(4)), a new agonist on rat midbrain synaptic terminal P2 receptors
- PMID: 10974322
- DOI: 10.1016/s0028-3908(00)00070-8
Adenosine 5'-tetraphosphate (Ap(4)), a new agonist on rat midbrain synaptic terminal P2 receptors
Abstract
The aim of this study was to see whether the compound adenosine 5'-tetraphosphate (Ap(4)) is active in the central nervous system by examining its effect on isolated rat brain synaptic terminals. Ap(4) proved to be more resistant to ecto-enzymatic hydrolysis than adenosine triphosphate (ATP), showing only 2% hydrolysis after a 2-min incubation, compared to 75% for ATP. In addition, Ap(4) was able to produce concentration-dependent increases in intracellular Ca(2+) when applied extracellularly. This action was dependent upon the presence of extracellular calcium. Ap(4) acts through ionotropic ATP receptors (P2X receptors) and not through diadenosine polyphosphate receptors, since ATP abolished the response elicited by Ap(4) whereas Ap(5)A did not. Ap(4), ATP and ATP-gamma-S were of similar potency (EC(50) approximately 20 microM) while 2MeSATP, alpha,beta-meATP and ADP-beta-S possessed slightly lower potency (EC(50) approximately 50 microM). The P2-purinoceptor antagonists suramin and PPADS blocked the Ap(4) effect. The IC(50) values for these compounds were 35.5 and 7.8 microM respectively. Diinosine polyphosphates and inosine tetraphosphate inhibited the response elicited by Ap(4) with IC(50) values that varied between approximately 40 and 50 microM. These results show that Ap(4) is as good an agonist as ATP on synaptosomal P2X receptors, being more resistant to extracellular hydrolysis by ecto-nucleotidases.
Similar articles
-
A novel receptor for diadenosine polyphosphates coupled to calcium increase in rat midbrain synaptosomes.Br J Pharmacol. 1995 Jul;115(6):895-902. doi: 10.1111/j.1476-5381.1995.tb15894.x. Br J Pharmacol. 1995. PMID: 7582517 Free PMC article.
-
Characterization of [35S]-ATP alpha S and [3H]-alpha, beta-MeATP binding sites in rat brain cortical synaptosomes: regulation of ligand binding by divalent cations.Br J Pharmacol. 1997 Jul;121(5):913-22. doi: 10.1038/sj.bjp.0701217. Br J Pharmacol. 1997. PMID: 9222547 Free PMC article.
-
Ap4A and ADP-beta-S binding to P2 purinoceptors present on rat brain synaptic terminals.Br J Pharmacol. 1993 Apr;108(4):1094-9. doi: 10.1111/j.1476-5381.1993.tb13510.x. Br J Pharmacol. 1993. PMID: 8485620 Free PMC article.
-
Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors.J Neurosci. 1998 Mar 15;18(6):1987-95. doi: 10.1523/JNEUROSCI.18-06-01987.1998. J Neurosci. 1998. PMID: 9482785 Free PMC article. Review.
-
Dinucleoside polyphosphates and their interaction with other nucleotide signaling pathways.Pflugers Arch. 2006 Aug;452(5):563-72. doi: 10.1007/s00424-006-0066-5. Epub 2006 May 11. Pflugers Arch. 2006. PMID: 16688466 Review.
Cited by
-
Diadenosine tetraphosphate (Ap4A) inhibits ATP-induced excitotoxicity: a neuroprotective strategy for traumatic spinal cord injury treatment.Purinergic Signal. 2017 Mar;13(1):75-87. doi: 10.1007/s11302-016-9541-4. Epub 2016 Oct 19. Purinergic Signal. 2017. PMID: 27761681 Free PMC article.
-
Migraine signaling pathways: purine metabolites that regulate migraine and predispose migraineurs to headache.Mol Cell Biochem. 2023 Dec;478(12):2813-2848. doi: 10.1007/s11010-023-04701-7. Epub 2023 Mar 22. Mol Cell Biochem. 2023. PMID: 36947357 Review.
-
Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.Bioorg Med Chem. 2008 Jun 15;16(12):6319-32. doi: 10.1016/j.bmc.2008.05.013. Epub 2008 May 9. Bioorg Med Chem. 2008. PMID: 18514530 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous